Charles Schwab Investment Management Inc. Boosts Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX)

Charles Schwab Investment Management Inc. raised its holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) by 5.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 480,123 shares of the company’s stock after acquiring an additional 26,262 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.13% of GoodRx worth $3,332,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. nVerses Capital LLC bought a new position in shares of GoodRx in the third quarter worth approximately $33,000. Plato Investment Management Ltd bought a new position in shares of GoodRx in the 2nd quarter worth $43,000. Dark Forest Capital Management LP bought a new position in shares of GoodRx in the 2nd quarter worth $86,000. Quest Partners LLC purchased a new stake in shares of GoodRx during the 3rd quarter valued at $160,000. Finally, Deerfield Management Company L.P. Series C bought a new stake in shares of GoodRx during the 2nd quarter worth $173,000. Institutional investors own 63.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on GDRX. Barclays reduced their target price on GoodRx from $10.00 to $6.00 and set an “overweight” rating on the stock in a research note on Monday, November 11th. Mizuho assumed coverage on GoodRx in a research report on Wednesday, December 4th. They set a “neutral” rating and a $5.00 price objective on the stock. Finally, Citigroup dropped their target price on GoodRx from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, GoodRx has an average rating of “Moderate Buy” and an average price target of $8.60.

GoodRx Stock Up 0.2 %

Shares of GoodRx stock opened at $4.71 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.48 and a current ratio of 5.48. GoodRx Holdings, Inc. has a 52-week low of $4.09 and a 52-week high of $9.26. The stock has a market capitalization of $1.80 billion, a price-to-earnings ratio of -157.00, a P/E/G ratio of 3.54 and a beta of 1.29. The company’s 50 day moving average price is $5.58 and its 200-day moving average price is $7.08.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.